Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study

Table 3 The comparison of drugs treatment used between 50 severe acute respiratory infection (sARI) cases and 79 controls infected with pH1N1 influenza

Drugs	Number exposed		Percent exposed		Matched odds ratio^a (95%CI)	Conditional logistic regression
Drugs	Case (N = 50)	Control (N = 79)	Case	Control	Matched odds ratio^a (95%CI)	Conditional logistic regression
Glucocorticosteroids^b	30	5	60.0	6.3	16.7(5.8–47.7)	8.2(2.3–29.0)
Pyrazolones^c	15	6	30.0	7.6	4.7(1.6–13.7)	3.3(0.8–14.6)
Neuraminidase inhibitor	37	7	74.0	8.9	24.5(8.7–68.4)	14.8(4.9–45.2)
Amantidine	3	6	6.0	7.6	0.9(0.2–3.8)
Ribavirin	27	36	54.0	45.6	1.3(0.6–2.8)
Other antivirals	15	32	30.0	40.5	0.6(0.2–1.3)
Antibiotics	47	67	94.0	84.8	3.4(0.8–13.4)	1.0(0.2–5.5)
Acetaminophen	15	17	30.0	21.5	1.7(0.7–3.8)
Ibuprofen	15	16	30.0	20.3	2.1(0.9–5.0)	2.1(0.7–7.1)
Nimesulide	9	15	18.0	19.0	1.0(0.4–2.7)
Traditional Chinese medicine	33	59	66.0	74.7	0.5(0.2–1.2)

^aOdds Ratio is matched by underlying disease, ^bdexamethasone or methyl prednisolone, ^caminopyrine or dipyrone

ISSN: 1471-2334